pharma · Influenza, Human · Influenza
Seqirus USA
Seqirus (Australia) Pty Ltd
Seqirus (Australia) Pty is a pharma organization headquartered in AU. Primary therapeutic focus areas include Influenza, Human, Influenza, Influenza Virus. NovaPharmaNews links 9 clinical program(s), 11 drug profile(s),
Summit, USA HQ
8 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Summit, USA
- Employees
- 8
- Programs
- 9
- Drugs
- 19
- Patents
- 0
Trivalent influenza vaccine (TIVc)
Phase 2 · mab · Influenza
Trivalent influenza vaccine (TIVc) for Influenza is a Phase 2 program (mab) at Seqirus (Australia) Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code V58P16
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Seqirus (Australia) Pty Ltd
- Phase
- Phase 2
- Modality
- mab
- Indication
- Influenza
- Status
- completed
- Trials
- 1